Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy

AUTOR(ES)

O'Brien, Matthew Frank

FONTE

American Society of Clinical Oncology

Documentos Relacionados

• Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
• Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients
• Urology: Prostate-Specific Antigen
• Prostate-specific antigen in screening for prostate cancer.
• Serum prostate-specific antigen assay--an update.